Related Experiment Video
Updated: May 6, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Interleukins and atherosclerosis: a dysfunctional family grows
Larry D Spears1, Babak Razani, Clay F Semenkovich
1Department of Medicine, Division of Endocrinology, Metabolism & Lipid Research, Washington University, St. Louis, MO 63110, USA.
Interleukin-1 alpha (IL-1α) is selectively induced by fatty acids, promoting vascular inflammation in atherosclerosis. This pathway is independent of the inflammasome, offering new insights into cardiovascular disease mechanisms.
Area of Science:
- Immunology
- Cardiovascular Biology
- Molecular Medicine
Background:
- Atherosclerosis pathogenesis involves cytokine release from macrophages.
- Interleukin-1 beta (IL-1β) is implicated in disease progression.
Purpose of the Study:
- Investigate the role of Interleukin-1 alpha (IL-1α) in vascular inflammation.
- Determine the mechanisms of IL-1α induction by fatty acids.
Main Methods:
- Cellular assays to measure cytokine induction.
- Analysis of inflammasome-independent pathways.
- Studies on fatty acid-mediated signaling.
Main Results:
- Fatty acids selectively induce IL-1α expression.
- IL-1α induction occurs independently of the inflammasome.
- IL-1α promotes vascular inflammation.
Conclusions:
- IL-1α is a key mediator of fatty acid-induced vascular inflammation.
- The inflammasome-independent pathway of IL-1α activation is critical in atherosclerosis.
- Targeting IL-1α may offer therapeutic strategies for cardiovascular disease.
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Chronic Inflammation: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease
Coronary Artery Disease II: Pathophysiology

